
ACXP
Healthcare · Biotechnology · $5.8M market cap
$0.9600-0.03 (-2.5%)Nov 13, 4:09 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -1.1% over 90 days · 30-day revisions 2 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Before the open | -0.45 | -0.49 | -8.9% |
| Aug 13, 2026 | After the close | -0.42 | -0.53 | -26.2% |
| May 11, 2026 | After the close | -0.63 | -0.62 | +1.6% |
| Mar 13, 2026 | Time not confirmed | -0.99 | -0.31 | +68.8% |
| Nov 12, 2025 | Before the open | -1.48 | -1.23 | +16.9% |
| Aug 11, 2025 | After the close | -2.10 | -1.89 | +10.0% |
| May 12, 2025 | After the close | -2.80 | -2.20 | +21.4% |
| Mar 17, 2025 | Before the open | -0.18 | -0.16 | +11.1% |
| Nov 12, 2024 | After the close | -4.60 | -3.40 | +26.1% |
| Aug 8, 2024 | After the close | -5.60 | -5.20 | +7.1% |
| May 14, 2024 | After the close | -4.80 | -5.60 | -16.7% |
| Mar 15, 2024 | After the close | -0.26 | -0.37 | -42.3% |
| Nov 13, 2023 | After the close | -5.00 |
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and…
| -4.80 |
| +4.0% |
| Aug 11, 2023 | After the close | -4.60 | -5.60 | -21.7% |
| May 12, 2023 | Before the open | -0.29 | -0.25 | +13.8% |
| Mar 15, 2023 | After the close | -6.20 | -5.60 | +9.7% |
| Nov 10, 2022 | After the close | -6.80 | -6.40 | +5.9% |
| Aug 12, 2022 | After the close | -7.00 | -5.20 | +25.7% |
| May 10, 2022 | After the close | -6.60 | -5.20 | +21.2% |
| Mar 16, 2022 | After the close | -0.40 | -0.22 | +45.0% |
| Nov 12, 2021 | After the close | -0.46 | -0.21 | +54.3% |
| Aug 13, 2021 | After the close | -0.57 | -0.57 | 0.0% |
| Jun 28, 2021 | Before the open | 0.00 | -0.48 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.11 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | -0.21 | — |
| Jun 30, 2020 | Time not confirmed | 0.00 | -0.15 | — |